Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Uno studio per valutare il cambiamento nell'attività della malattia e gli eventi avversi di Upadacitinib orale in partecipanti adulti e adolescenti con idrosadenite suppurativa da moderata a grave che hanno fallito la terapia anti-TNF (Step-Up HS)

10 novembre 2026 aggiornato da: AbbVie

Uno studio di fase 3, randomizzato, controllato con placebo, in doppio cieco per valutare l'efficacia e la sicurezza di Upadacitinib in soggetti adulti e adolescenti con idrosadenite suppurativa da moderata a grave che hanno fallito la terapia anti-TNF

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed.

Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of HS. This study is "double-blinded", meaning that neither the trial participants nor the study doctors will know who will be given upadacitinib and who will be given placebo. This study is comprised of 3 periods. In Period 1, participants are randomized into 2 groups called treatment arms where each group receives a different treatment. There is a 1 in 2 chance that participants will be assigned to placebo. In Period 2, participants are placed into 6 different groups depending on their placement and results in Period 1. Period 3 is the long-term extension period where participants will continue treatment from Period 2. Approximately 1328 adult and adolescent participants diagnosed with HS will be enrolled in approximately 300 sites worldwide.

Participants will receive oral tablets of upadacitinib or placebo once daily for 36 weeks in Period 1 and Period 2. Eligible participants from Period 1 and Period 2 will enter Period 3 and receive oral tablets of upadacitinib or placebo once daily for 68 weeks. Participants will be followed up for approximately 30 days.

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular outpatient visits during the study. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.

Panoramica dello studio

Stato

Attivo, non reclutante

Tipo di studio

Interventistico

Iscrizione (Stimato)

1328

Fase

  • Fase 3

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Riyadh, Arabia Saudita, 12372
        • King Saud University Med City /ID# 255282
    • Mecca Region
      • Jeddah, Mecca Region, Arabia Saudita, 23433
        • King Faisal Specialist Hospital /ID# 255539
    • Riyadh Region
      • Riyadh, Riyadh Region, Arabia Saudita, 11211
        • King Faisal Specialist Hospital and Research Centre /ID# 255279
      • Riyadh, Riyadh Region, Arabia Saudita, 11426
        • King Abdulaziz Medical City- National Guard Hospital /ID# 255280
      • Buenos Aires, Argentina, 1061
        • Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 255474
      • CABA, Argentina, C1199ABB
        • Hospital Italiano /ID# 254905
    • Buenos Aires
      • Pilar, Buenos Aires, Argentina, 1629
        • Hospital Universitario Austral /ID# 254904
    • Buenos Aires F.D.
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1055
        • Buenos Aires Skin /ID# 255299
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Instituto de Neumonologia y Dermatologia /ID# 254903
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Psoriahue Med Interdisciplinar /ID# 257202
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1428
        • Consultorios Reumatologicos Pampa /ID# 255555
    • Australian Capital Territory
      • Phillip, Australian Capital Territory, Australia, 2606
        • Paratus Clinical Research Woden /ID# 254670
    • New South Wales
      • Darlinghurst, New South Wales, Australia, 2010
        • Momentum Clinical Research /ID# 254411
    • Victoria
      • Carlton, Victoria, Australia, 3053
        • Skin Health Institute Inc /ID# 254416
      • East Melbourne, Victoria, Australia, 3002
        • Sinclair Dermatology - Melbourne /ID# 254412
      • Melbourne, Victoria, Australia, 3004
        • The Alfred Hospital /ID# 254414
    • State of Vienna
      • Vienna, State of Vienna, Austria, 1090
        • Medizinische Universitaet Wien /ID# 254096
    • Styria
      • Graz, Styria, Austria, 8010
        • Medizinische Universitaet Graz /ID# 253448
    • Upper Austria
      • Linz, Upper Austria, Austria, 4010
        • Duplicate_Ordensklinikum Linz GmbH Elisabethinen /ID# 253458
      • Liège, Belgio, 4000
        • CHU de Liege /ID# 254085
    • Brussels Capital
      • Anderlecht, Brussels Capital, Belgio, 1070
        • Universite Libre de Bruxelles - Hopital Erasme /ID# 254082
      • Brussels, Brussels Capital, Belgio, 1200
        • Cliniques Universitaires UCL Saint-Luc /ID# 254087
      • Jette, Brussels Capital, Belgio, 1090
        • Universitair Ziekenhuis Brussel /ID# 254223
    • Hainaut
      • Charleroi, Hainaut, Belgio, 6280
        • Grand Hopital de Charleroi - Les Viviers /ID# 254091
    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Belgio, 9000
        • UZ Gent /ID# 254090
    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgio, 3000
        • Universitair Ziekenhuis Leuven /ID# 254089
      • Rio de Janeiro, Brasile, 20241-180
        • Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 275810
      • São Paulo, Brasile, 05403-000
        • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 254370
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasile, 90035-001
        • Hospital Moinhos de Vento /ID# 254366
    • Rio de Janeiro
      • Macaé, Rio de Janeiro, Brasile, 27910-190
        • Instituto de Pesquisa e Ensino CLIGEDIMUNO - IPEC /ID# 254369
    • São Paulo
      • Campinas, São Paulo, Brasile, 13034-685
        • Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 275811
      • Ribeirão Preto, São Paulo, Brasile, 14049-900
        • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 254367
      • São Paulo, São Paulo, Brasile, 04020-060
        • Centro de Desenvolvimento em Estudos Clinicos Brasil - CDEC /ID# 254368
      • Sofia, Bulgaria, 1407
        • Acibadem City Clinic Tokuda University Hospital EAD /ID# 253331
      • Stara Zagora, Bulgaria, 6000
        • UMHAT Professor Stoyan Kirkovich /ID# 253328
    • Sofia
      • Sofiya, Sofia, Bulgaria, 1407
        • Ambulatory for Specialized Medical Care-IPSMC-skin and venereal diseases /ID# 253329
      • Sofiya, Sofia, Bulgaria, 1463
        • Diagnostic Consultative Centre (Dcc) - Foкus 5 /ID# 253327
      • Québec, Canada, G1V 4T3
        • Diex Recherche Quebec Inc. /ID# 254381
    • Alberta
      • Calgary, Alberta, Canada, T2J 7E1
        • Dermatology Research Institute - Blackfoot Trail /ID# 261413
      • Calgary, Alberta, Canada, T3A 2N1
        • Beacon Dermatology /ID# 254564
      • Edmonton, Alberta, Canada, T5J 3S9
        • Rejuvenation Dermatology - Edmonton Downtown /ID# 254715
      • Edmonton, Alberta, Canada, T6G 1C3
        • Alberta Dermasurgery Centre /ID# 275945
      • Red Deer, Alberta, Canada, T4P 1K4
        • Care Clinic - Red Deer - Taylor Drive /ID# 276063
    • British Columbia
      • Surrey, British Columbia, Canada, V3R 6A7
        • Dr. Chih-ho Hong Medical Inc. /ID# 254378
      • Surrey, British Columbia, Canada, V3V 0C6
        • Enverus Medical Research /ID# 254380
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3M 3Z4
        • Wiseman Dermatology Research /ID# 254117
    • Newfoundland and Labrador
      • St. John's, Newfoundland and Labrador, Canada, A1A 4Y3
        • Karma Clinical Trials /ID# 254120
    • Ontario
      • Hamilton, Ontario, Canada, L8L 3C3
        • LEADER Research /ID# 254379
      • London, Ontario, Canada, N6H 5L5
        • DermEffects /ID# 254116
      • Markham, Ontario, Canada, L3P 1X2
        • Lynderm Research /ID# 254713
      • Mississauga, Ontario, Canada, L4W 0C2
        • Derm Care Clinic /ID# 276065
      • Newmarket, Ontario, Canada, L3Y 5G8
        • Ryan Clinical Research Inc /ID# 254714
      • Richmond Hill, Ontario, Canada, L4C 9M7
        • York Dermatology Clinic and Research Centre /ID# 254115
      • Toronto, Ontario, Canada, M4W 2N4
        • Research Toronto /ID# 255273
    • Quebec
      • Montreal, Quebec, Canada, H3T 1C5
        • Centre Hospitalier Universitaire (CHU) Sainte-Justine /ID# 254118
      • Saint-Jérôme, Quebec, Canada, J7Z 7E2
        • Dre Angelique Gagne-Henley M.D. inc. /ID# 255632
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada, S7K 0H6
        • SkinSense Dermatology /ID# 254119
      • Karlovy Vary, Cechia, 360 01
        • Karlovarska Krajska Nemocnice - Karlovy Vary /ID# 253456
      • Prague, Cechia, 100 34
        • Fakultni nemocnice Kralovske Vinohrady /ID# 253454
    • Praha 5
      • Prague, Praha 5, Cechia, 150 06
        • Fakultni nemocnice Motol a Homolka /ID# 253455
    • Region Metropolitana Santiago
      • Las Condes, Region Metropolitana Santiago, Chile, 7580206
        • Centro Medico Skin Med SPA /ID# 254560
      • Santiago, Region Metropolitana Santiago, Chile, 8420383
        • Centro Internacional de Estudios Clinicos - CIEC /ID# 254559
      • Vitacura, Region Metropolitana Santiago, Chile, 7640881
        • Clinica Dermacross /ID# 254558
    • Santiago Metropolitan
      • Independencia, Santiago Metropolitan, Chile, 8380465
        • Fundacion Innovacion Cardiovascular /ID# 254561
    • Antioquia
      • Medellín, Antioquia, Colombia, 050012
        • Clinica De Inmunologia Y Genetica (Cige) /ID# 254797
      • Medellín, Antioquia, Colombia, 050016
        • IPS Suramericana SAS - IPS Sura San Diego /ID# 255064
    • Atlántico
      • Barranquilla, Atlántico, Colombia, 80002
        • Centro Integral de Reumatologia del Caribe SAS - Circaribe SAS /ID# 255278
    • Cundinamarca
      • Bogotá, Cundinamarca, Colombia, 110221
        • Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 254796
    • Gyeonggido
      • Ansan-si, Gyeonggido, Corea del Sud, 15355
        • Korea University Ansan Hospital /ID# 254128
      • Seongnam, Gyeonggido, Corea del Sud, 13496
        • CHA Bundang Medical Center /ID# 254026
    • Seoul Teugbyeolsi
      • Seoul, Seoul Teugbyeolsi, Corea del Sud, 03080
        • Seoul National University Hospital /ID# 254027
      • Seoul, Seoul Teugbyeolsi, Corea del Sud, 04401
        • SoonChunHyang University Seoul Hospital /ID# 254025
      • Seoul, Seoul Teugbyeolsi, Corea del Sud, 07441
        • Hallym University Kangnam Sacred Heart Hospital /ID# 254127
    • City of Zagreb
      • Zagreb, City of Zagreb, Croazia, 10000
        • DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 253587
      • Zagreb, City of Zagreb, Croazia, 10000
        • Klinicki bolnicki centar Zagreb /ID# 253786
      • Zagreb, City of Zagreb, Croazia, 10000
        • Klinika za dječje bolesti Zagreb /ID# 253588
      • Zagreb, City of Zagreb, Croazia, 10000
        • Poliklinika Solmed /ID# 254732
    • Primorje-Gorski Kotar County
      • Rijeka, Primorje-Gorski Kotar County, Croazia, 51000
        • Specialty Hospital Medico /ID# 254731
    • Split-Dalmatia County
      • Split, Split-Dalmatia County, Croazia, 21000
        • Klinicki Bolnicki Centar Split /ID# 253789
    • Zagreb County
      • Ivanić-Grad, Zagreb County, Croazia, 10310
        • Naftalan - Specijalna bolnica za medicinsku rehabilitaciju /ID# 253586
    • North Ostrobothnia
      • Oulu, North Ostrobothnia, Finlandia, 90220
        • Oulun yliopistollinen sairaala /ID# 253969
    • Pirkanmaa
      • Tampere, Pirkanmaa, Finlandia, 33100
        • Terveystalo Tampere /ID# 253968
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, Francia, 06202
        • Chu De Nice-Hopital Larchet II /ID# 253504
    • Gironde
      • Bordeaux, Gironde, Francia, 33000
        • Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 254139
    • Marne
      • Reims, Marne, Francia, 51100
        • Polyclinique Courlancy /ID# 254680
    • Pays de la Loire Region
      • Nantes, Pays de la Loire Region, Francia, 44000
        • Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 254114
    • Rhone
      • Lyon, Rhone, Francia, 69003
        • HCL - Hopital Edouard Herriot /ID# 253500
    • Île-de-France Region
      • Antony, Île-de-France Region, Francia, 92160
        • Hopital Prive d'Antony /ID# 253501
      • Berlin, Germania, 13595
        • Havelklinik /ID# 254194
      • Magdeburg, Germania, 39104
        • Magdeburger Company for Medical Studies & Services GmbH /ID# 255151
      • Mainz, Germania, 55128
        • Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 253691
    • Baden-Wurttemberg
      • Freiburg im Breisgau, Baden-Wurttemberg, Germania, 79106
        • Universitaetsklinikum Freiburg /ID# 275746
    • Bavaria
      • Erlangen, Bavaria, Germania, 91054
        • Universitaetsklinikum Erlangen /ID# 254804
      • Munich, Bavaria, Germania, 80802
        • Klinikum rechts der Isar Technische Universitat Munchen /ID# 254195
      • Regensburg, Bavaria, Germania, 93042
        • Universitaetsklinikum Regensburg /ID# 253692
      • Würzburg, Bavaria, Germania, 97080
        • Universitaetsklinikum Wuerzburg /ID# 275599
    • Hesse
      • Frankfurt am Main, Hesse, Germania, 60590
        • Universitaetsklinikum Frankfurt /ID# 253683
    • Lower Saxony
      • Bad Bentheim, Lower Saxony, Germania, 48455
        • Fachklinik - Bad Bentheim /ID# 275537
      • Bramsche, Lower Saxony, Germania, 49565
        • Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 254510
    • North Rhine-Westphalia
      • Bochum, North Rhine-Westphalia, Germania, 44791
        • Universitaetsklinikum Der Ruhr-Universitaet Bochum /ID# 253690
      • Düsseldorf, North Rhine-Westphalia, Germania, 40225
        • Universitaetsklinikum Duesseldorf /ID# 253711
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germania, 55131
        • Universitaetsmedizin Mainz /ID# 272596
    • Saarland
      • Merzig, Saarland, Germania, 66663
        • Hautmedizin Saar Science /ID# 272614
    • Fukuoka
      • Fukuoka, Fukuoka, Giappone, 814-0180
        • Fukuoka University Hospital /ID# 254729
    • Hyōgo
      • Nishinomiya-shi, Hyōgo, Giappone, 663-8186
        • Meiwa Hospital /ID# 254728
    • Ibaraki
      • Tsukuba, Ibaraki, Giappone, 305-8576
        • University of Tsukuba Hospital /ID# 254638
    • Kyoto
      • Kyoto, Kyoto, Giappone, 602-8566
        • University Hospital Kyoto Prefectural University of Medicine /ID# 254481
    • Miyagi
      • Sendai, Miyagi, Giappone, 9808574
        • Tohoku University Hospital /ID# 254598
    • Okinawa
      • Ginowan-shi, Okinawa, Giappone, 901-2725
        • University of the Ryukyus Hospital /ID# 254517
    • Osaka
      • Sakai-shi, Osaka, Giappone, 590-0197
        • Kindai University Hospital /ID# 254574
    • Shiga
      • Ōtsu, Shiga, Giappone, 520-2192
        • Shiga University of Medical Science Hospital /ID# 254215
    • Tokyo
      • Minato-ku, Tokyo, Giappone, 105-8470
        • Toranomon Hospital /ID# 253819
      • tabashi City, Tokyo, Giappone, 173-8610
        • Nihon University Itabashi Hospital /ID# 254637
      • Thessaloniki, Grecia, 54643
        • Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 253497
      • Thessaloniki, Grecia, 56429
        • Papageorgiou General Hospital /ID# 253496
    • Attica
      • Athens, Attica, Grecia, 11527
        • 401 GSNA - 401 Army General Hospital /ID# 253499
      • Athens, Attica, Grecia, 16121
        • General Hospital Andreas Syggros /ID# 253498
      • Chaïdári, Attica, Grecia, 12462
        • University General Hospital Attikon /ID# 253495
      • Cork, Irlanda, T12 X23H
        • South Infirmary Victoria University Hospital /ID# 253975
      • Dublin, Irlanda, D04 T6F4
        • St. Vincent's University Hospital /ID# 253971
      • Galway, Irlanda, H91 YR71
        • University Hospital Galway /ID# 253976
      • Waterford, Irlanda, X91 ER8E
        • Waterford Regional Hospital /ID# 254038
    • Dublin
      • Dublin, Dublin, Irlanda, D08 NHY1
        • St James Hospital /ID# 253973
      • Haifa, Israele, 3109601
        • Rambam Health Care Campus /ID# 254406
    • Central District
      • Petah Tikva, Central District, Israele, 4941492
        • Rabin Medical Center. /ID# 254405
    • Northern District
      • Safed, Northern District, Israele, 13100
        • ZIV Medical Center /ID# 254403
    • Tel Aviv
      • Ramat Gan, Tel Aviv, Israele, 52621
        • Sheba Medical Center /ID# 254545
      • Tel Aviv, Tel Aviv, Israele, 6423906
        • Tel Aviv Sourasky Medical Center /ID# 254404
      • Brescia, Italia, 25123
        • ASST degli Spedali Civili di Brescia /ID# 254875
      • Milan, Italia, 20122
        • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 254502
      • Modena, Italia, 41124
        • Azienda Ospedaliero-Universitaria di Modena /ID# 254874
      • Pisa, Italia, 56126
        • Azienda Ospedaliero Universitaria Pisana /ID# 254501
    • Ferrara
      • Cona, Ferrara, Italia, 44124
        • Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale S.Anna /ID# 254496
    • Firenze
      • Florence, Firenze, Italia, 50122
        • AZIENDA USL TOSCANA CENTRO - Ospedale Piero Palagi /ID# 254495
    • L Aquila
      • L’Aquila, L Aquila, Italia, 67100
        • ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 276045
    • Roma
      • Rome, Roma, Italia, 00133
        • Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 254498
      • Rome, Roma, Italia, 00168
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 254500
      • Vilnius, Lituania, 08406
        • Inlita - Santara KTC /ID# 253917
      • Vilnius, Lituania, 08661
        • Vilnius University Hospital Santaros Klinikos /ID# 253916
      • Mexico City, Messico, 06100
        • Cryptex Investigacion Clinica S.A de C.V /ID# 256066
    • Jalisco
      • Guadalajara, Jalisco, Messico, 44657
        • Grupo Clinico Catei Sociedad Civil /Id# 254657
    • Nuevo León
      • Monterrey, Nuevo León, Messico, 64718
        • Eukarya PharmaSite, SC /ID# 254658
    • Auckland
      • Epsom, Auckland, Nuova Zelanda, 1051
        • Greenlane Clinical Centre /ID# 254351
    • Waikato Region
      • Hamilton, Waikato Region, Nuova Zelanda, 3204
        • Clinical Trials New Zealand /ID# 254352
      • Groningen, Olanda, 9713 GZ
        • Universitair Medisch Centrum Groningen /ID# 253571
    • North Brabant
      • Breda, North Brabant, Olanda, 4818 CK
        • Amphia Ziekenhuis /ID# 253567
      • Caguas, Porto Rico, 00727
        • Dr. Samuel Sanchez PSC /ID# 253948
      • Carolina, Porto Rico, 00985
        • Alma M. Cruz Santana, MD-Private practice /ID# 253951
      • Lisbon, Portogallo, 1998-018
        • Hospital CUF Descobertas /ID# 254323
      • Porto, Portogallo, 4099-001
        • Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 254322
      • Porto, Portogallo, 4200-319
        • Unidade Local de Saude Sao Joao /ID# 254324
    • Lisbon District
      • Lisbon, Lisbon District, Portogallo, 1169-050
        • Centro Hospitalar de Lisboa Central - Lisbon /ID# 254325
      • Bristol, Regno Unito, BS1 3NU
        • University Hospitals Bristol /ID# 261505
      • Salford, Regno Unito, M6 8HD
        • Northern Care Alliance NHS Group /ID# 256910
    • Greater London
      • Isleworth, Greater London, Regno Unito, TW7 6AF
        • West Middlesex University Hospital /ID# 254190
      • London, Greater London, Regno Unito, SW17 0QT
        • St George University Hospitals NHS Foundation Trust /ID# 256803
    • Hampshire
      • Southampton, Hampshire, Regno Unito, SO16 6YD
        • University Hospital Southampton NHS Foundation Trust /ID# 254531
    • Warwickshire
      • Coventry, Warwickshire, Regno Unito, CV2 2DX
        • UH Coventry & Warwickshire /ID# 256909
    • West Yorkshire
      • Leeds, West Yorkshire, Regno Unito, LS9 7TF
        • Leeds Teaching Hospitals NHS Trust /ID# 254616
      • Singapore, Singapore, 119074
        • National University Hospital /ID# 254943
    • Central Singapore
      • Singapore, Central Singapore, Singapore, 308205
        • National Skin Centre /ID# 255242
    • Bratislava Region
      • Bratislava, Bratislava Region, Slovacchia, 821 01
        • Univerzitna nemocnica Bratislava - Nemocnica Ruzinov /ID# 254157
    • Košice Region
      • Košice, Košice Region, Slovacchia, 041 90
        • Univerzitna nemocnica L. Pasteura Kosice /ID# 254136
    • Nitra Region
      • Nové Zámky, Nitra Region, Slovacchia, 940 34
        • Fakultna nemocnica s poliklinikou Nove Zamky /ID# 254155
    • Trnava Region
      • Trnava, Trnava Region, Slovacchia, 917 02
        • Fakultna nemocnica Trnava /ID# 254137
    • Žilina Region
      • Martin, Žilina Region, Slovacchia, 036 01
        • Univerzitna nemocnica Martin /ID# 254153
      • Barcelona, Spagna, 08041
        • Hospital Santa Creu i Sant Pau /ID# 253869
      • Barcelona, Spagna, 08042
        • Hospital General de Granollers /ID# 253873
      • Granada, Spagna, 18014
        • Hospital Universitario Virgen de las Nieves /ID# 253870
      • Madrid, Spagna, 28034
        • Hospital Universitario Ramon y Cajal /ID# 253871
      • Valencia, Spagna, 46026
        • Hospital Universitario y Politecnico La Fe /ID# 253868
    • Barcelona
      • L'Hospitalet de Llobregat, Barcelona, Spagna, 08907
        • Hospital Universitari de Bellvitge /ID# 254982
    • Madrid
      • Majadahonda, Madrid, Spagna, 28222
        • Hospital Universitario Puerta de Hierro - Majadahonda /ID# 253924
    • Valencia
      • Manises, Valencia, Spagna, 46940
        • Hospital de Manises /ID# 253867
    • Alabama
      • Birmingham, Alabama, Stati Uniti, 35244
        • Cahaba Dermatology and Skin Health Center /ID# 254876
    • Arizona
      • Fountain Hills, Arizona, Stati Uniti, 85268
        • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564
      • Phoenix, Arizona, Stati Uniti, 85006
        • Medical Dermatology Specialists /ID# 254226
      • Scottsdale, Arizona, Stati Uniti, 85259
        • Mayo Clinic Hospital Scottsdale /ID# 254388
      • Tucson, Arizona, Stati Uniti, 85718-1407
        • Banner University Medicine Dermatology /ID# 255853
    • Arkansas
      • Fayetteville, Arkansas, Stati Uniti, 72703
        • Clinical Trials Institute - Northwest Arkansas /ID# 254924
      • Hot Springs, Arkansas, Stati Uniti, 71913-6404
        • Burke Pharmaceutical Research /ID# 254238
      • North Little Rock, Arkansas, Stati Uniti, 72217
        • Arkansas Research Trials /ID# 254233
      • Rogers, Arkansas, Stati Uniti, 72758
        • Northwest Arkansas Clinical Trials Center /ID# 254311
    • California
      • Encino, California, Stati Uniti, 91436
        • Private Practice - Dr. Tooraj Raoof /ID# 254374
      • Huntington Beach, California, Stati Uniti, 92647
        • Marvel Clinical Research /ID# 276228
      • Los Angeles, California, Stati Uniti, 90045
        • Dermatology Research Associates /ID# 254846
      • Rocklin, California, Stati Uniti, 95765
        • Norcal Clinical Research /ID# 274219
      • Sacramento, California, Stati Uniti, 95815
        • Integrative Skin Science and Research /ID# 254930
      • Sacramento, California, Stati Uniti, 95817
        • University of California Davis Health /ID# 254229
      • San Diego, California, Stati Uniti, 92103
        • Medderm Associates /ID# 253800
      • Thousand Oaks, California, Stati Uniti, 91320-2130
        • Clinical Trials Research Institute /ID# 254466
    • Connecticut
      • Farmington, Connecticut, Stati Uniti, 06032
        • UConn Health Main /ID# 254507
      • New Haven, Connecticut, Stati Uniti, 06510
        • Yale University School of Medicine /ID# 254586
    • Florida
      • Boca Raton, Florida, Stati Uniti, 33486-2269
        • Skin Care Research Boca Raton /ID# 253814
      • Brandon, Florida, Stati Uniti, 33511
        • Apex Clinical Trials /ID# 255756
      • Coral Gables, Florida, Stati Uniti, 33134-5755
        • Florida Academic Dermatology Center /ID# 254011
      • Coral Springs, Florida, Stati Uniti, 33071
        • Life Clinical Trials - Coral Springs /ID# 258613
      • Delray Beach, Florida, Stati Uniti, 33445
        • Dermatology Associates of the Palm Beaches /ID# 275950
      • Hollywood, Florida, Stati Uniti, 33021-6748
        • Skin Care Research - Hollywood /ID# 254508
      • Tampa, Florida, Stati Uniti, 33607-6438
        • Skin Care Research - Tampa /ID# 256440
      • Tampa, Florida, Stati Uniti, 33607
        • Advanced Clinical Research Institute - Tampa /ID# 253746
      • Tampa, Florida, Stati Uniti, 33613-1825
        • Avita Clinical Research /ID# 254471
    • Georgia
      • Columbus, Georgia, Stati Uniti, 31904-2954
        • Centricity Research - Columbus /ID# 255470
    • Idaho
      • Boise, Idaho, Stati Uniti, 83706
        • Treasure Valley Medical Research /ID# 255208
    • Illinois
      • Chicago, Illinois, Stati Uniti, 60602
        • Illinois Dermatology Institute - Chicago Loop Office /ID# 254372
      • Chicago, Illinois, Stati Uniti, 60611
        • Northwestern Medicine - Northwestern Memorial Hospital /ID# 254503
      • Skokie, Illinois, Stati Uniti, 60077
        • NorthShore University HealthSystem - Skokie /ID# 254389
    • Indiana
      • Indianapolis, Indiana, Stati Uniti, 46256
        • Dawes Fretzin /ID# 254390
      • West Lafayette, Indiana, Stati Uniti, 47906
        • Options Research Group /ID# 254537
    • Kansas
      • Leawood, Kansas, Stati Uniti, 66211-1453
        • U.S. Dermatology Partners Leawood /ID# 255838
    • Kentucky
      • Bowling Green, Kentucky, Stati Uniti, 42104
        • Equity Medical /ID# 271140
    • Massachusetts
      • Boston, Massachusetts, Stati Uniti, 02114
        • Massachusetts General Hospital /ID# 261093
      • Boston, Massachusetts, Stati Uniti, 02215-5400
        • Beth Israel Deaconess Medical Center /ID# 253811
      • Quincy, Massachusetts, Stati Uniti, 02169
        • Beacon Clinical Research, LLC /ID# 254419
      • Worcester, Massachusetts, Stati Uniti, 01655
        • UMass Memorial Medical Center - Lake Avenue North /ID# 258839
    • Michigan
      • Caledonia, Michigan, Stati Uniti, 49316
        • The Derm Institute Of West Michigan /ID# 275948
      • Canton, Michigan, Stati Uniti, 48187
        • Hamzavi Dermatology - Canton /ID# 275856
      • Clarkston, Michigan, Stati Uniti, 48346
        • Michigan Center for Medical Research - Clarkston /ID# 275860
      • Waterford, Michigan, Stati Uniti, 48328
        • Michigan Dermatology Institute /ID# 254468
    • Missouri
      • Kirksville, Missouri, Stati Uniti, 63501-5362
        • Cleaver Dermatology /ID# 254391
      • Lee's Summit, Missouri, Stati Uniti, 64064-2301
        • Dermatology and Skin Center of Lees Summit /ID# 257546
      • Saint Joseph, Missouri, Stati Uniti, 64506
        • MediSearch Clinical Trials /ID# 254392
      • St Louis, Missouri, Stati Uniti, 63104
        • SSM Health Saint Louis University Hospital /ID# 256437
      • St Louis, Missouri, Stati Uniti, 63130
        • Washington University School of Medicine - St. Louis /ID# 254506
    • Nevada
      • Las Vegas, Nevada, Stati Uniti, 89119-5190
        • Vivida Dermatology- Flamingo /ID# 254227
      • Las Vegas, Nevada, Stati Uniti, 89144
        • Las Vegas Dermatology /ID# 272421
      • Reno, Nevada, Stati Uniti, 89509
        • Skin Cancer and Dermatology Institute - Reno /ID# 254410
    • New York
      • East Syracuse, New York, Stati Uniti, 13057
        • Empire Dermatology /ID# 276241
      • New Hyde Park, New York, Stati Uniti, 11042-2058
        • NorthWell Health - Dermatology /ID# 254704
      • New York, New York, Stati Uniti, 07044-2946
        • Schweiger Dermatology, P.C. /ID# 254232
      • New York, New York, Stati Uniti, 10012
        • Private Practice - Dr. Bobby Buka /ID# 276371
    • North Carolina
      • Charlotte, North Carolina, Stati Uniti, 28277
        • OnSite Clinical Solutions - North Community House Road - Charlotte /ID# 254854
      • Durham, North Carolina, Stati Uniti, 27710
        • Duke University Medical Center /ID# 256898
    • Ohio
      • Canton, Ohio, Stati Uniti, 44718
        • Apex Clinical Research Center, LLC /ID# 275956
      • Columbus, Ohio, Stati Uniti, 43213-4440
        • ClinOhio Research Services /ID# 254851
      • Mason, Ohio, Stati Uniti, 45040-4520
        • Dermatologists of Southwest Ohio /ID# 254297
      • Medina, Ohio, Stati Uniti, 44256
        • Dermatology Partners - Medina /ID# 275939
    • Oklahoma
      • Oklahoma City, Oklahoma, Stati Uniti, 73112
        • Lynn Institute of Oklahoma City /ID# 253791
    • Oregon
      • Portland, Oregon, Stati Uniti, 97239
        • Oregon Health and Science University /ID# 254929
    • Pennsylvania
      • Hershey, Pennsylvania, Stati Uniti, 17033-2360
        • Penn State Milton S. Hershey Medical Center /ID# 254925
      • Philadelphia, Pennsylvania, Stati Uniti, 19103
        • Paddington Testing Co., Inc. /ID# 254394
      • Philadelphia, Pennsylvania, Stati Uniti, 19114
        • Clinical Research of Philadelphia, LLC /ID# 255308
    • South Carolina
      • Charleston, South Carolina, Stati Uniti, 29425
        • Medical University of South Carolina /ID# 272569
    • Tennessee
      • Knoxville, Tennessee, Stati Uniti, 37917
        • Dermatology Associates of Knoxville /ID# 261082
    • Texas
      • Arlington, Texas, Stati Uniti, 76011
        • Arlington Research Center, Inc /ID# 253805
      • Bellaire, Texas, Stati Uniti, 77401
        • Bellaire Dermatology Associates /ID# 253797
      • Dallas, Texas, Stati Uniti, 75230
        • Dermatology Treatment and Research Center /ID# 253795
      • Dallas, Texas, Stati Uniti, 75231
        • Modern Research Associates /ID# 253810
      • Dallas, Texas, Stati Uniti, 75240-6246
        • HRMD Research Dallas /ID# 255256
      • Grapevine, Texas, Stati Uniti, 76051-3580
        • Dallas Fort Worth Clinical Research Associates (DFWCRA) /ID# 256438
      • Houston, Texas, Stati Uniti, 77056
        • Suzanne Bruce and Associates-Houston /ID# 254228
      • Plano, Texas, Stati Uniti, 75025
        • Texas Dermatology Research Center /ID# 254928
      • Webster, Texas, Stati Uniti, 77598
        • Center for Clinical Studies Webster /ID# 254242
    • Utah
      • Bountiful, Utah, Stati Uniti, 84010
        • Cope Family Medicine - Ogden Clinic /ID# 276227
      • Murray, Utah, Stati Uniti, 84107
        • University of Utah - Murray /ID# 254452
      • Springville, Utah, Stati Uniti, 84663
        • Springville Dermatology - Springville /ID# 276225
    • Virginia
      • Charlottesville, Virginia, Stati Uniti, 22903
        • University of Virginia - Dermatology /ID# 254535
      • Lynchburg, Virginia, Stati Uniti, 24501-1403
        • The Education & Research Foundation, Inc. /ID# 254852
      • Norfolk, Virginia, Stati Uniti, 23507
        • Virginia Clinical Research /ID# 254538
    • Washington
      • Mill Creek, Washington, Stati Uniti, 98012
        • Frontier Dermatology /ID# 254554
      • Spokane, Washington, Stati Uniti, 99202
        • Premier Clinical Research /ID# 254847
    • Stockholm County
      • Solna, Stockholm County, Svezia, 171 64
        • Karolinska University Hospital Solna /ID# 254808
    • Västra Götaland County
      • Gothenburg, Västra Götaland County, Svezia, 413 46
        • Sahlgrenska Universitetssjukhuset /ID# 254807
      • Bern, Svizzera, 3010
        • Inselspital, Universitaetsspital Bern /ID# 254736
    • Canton of St. Gallen
      • Sankt Gallen, Canton of St. Gallen, Svizzera, 9007
        • Kantonsspital St. Gallen /ID# 255243
    • Canton of Zurich
      • Zurich, Canton of Zurich, Svizzera, 8091
        • University Hospital Zurich /ID# 254642
      • Changhua City, Changhua County, Taiwan, 50006
        • Changhua Christian Hospital /ID# 254032
      • Kaohsiung City, Taiwan, 833
        • Kaohsiung Chang Gung Memorial Hospital /ID# 254031
      • Taipei, Taiwan, 100
        • National Taiwan University Hospital /ID# 254030
      • Taoyuan City, Taiwan, 333
        • Linkou Chang Gung Memorial Hospital /ID# 254033
      • Bayraklı, Turchia (Türkiye), 35540
        • Izmir Sehir Hastanesi /ID# 265465
      • Bursa, Turchia (Türkiye), 16059
        • Uludag University Medical Faculty /ID# 253806
      • Istanbul, Turchia (Türkiye), 34098
        • Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 253824
      • Kayseri, Turchia (Türkiye), 38039
        • Erciyes University Medical Faculty /ID# 253804
      • Samsun, Turchia (Türkiye), 55139
        • Ondokuz Mayis Universitesi /ID# 254034
    • Antalya
      • Ankara, Antalya, Turchia (Türkiye), 06010
        • Gulhane Egitim ve Arastirma Hastanesi /ID# 253919
      • Budapest, Ungheria, 1027
        • Csalogany Orvosi Kozpont /ID# 255063
      • Budapest, Ungheria, 1036
        • Duplicate_Obudai Egeszsegugyi Centrum Kft. /ID# 256366
      • Budapest, Ungheria, 1085
        • Semmelweis Egyetem /ID# 276162
      • Debrecen, Ungheria, 4031
        • DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 253638
    • Baranya
      • Pécs, Baranya, Ungheria, 7624
        • Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 253753
    • Csongrád megye
      • Szeged, Csongrád megye, Ungheria, 6720
        • Szegedi Tudomanyegyetem /ID# 255142
    • Hajdú-Bihar
      • Debrecen, Hajdú-Bihar, Ungheria, 4032
        • Debreceni Egyetem-Klinikai Kozpont /ID# 253637
    • Somogy County
      • Kaposvár, Somogy County, Ungheria, 7400
        • Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 253913
    • Vas County
      • Szombathely, Vas County, Ungheria, 9700
        • Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 254377

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

12 anni e precedenti (Bambino, Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Diagnosis of hidradenitis suppurativa (HS) for at least 6 months prior to Baseline, as determined by the investigator (i.e., through medical history and interview of participant).
  • Documented history of previous use of >= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic therapy for HS for at least 16 weeks characterized by inadequate response or for any duration characterized by intolerance as determined by the investigator.
  • Participant must have a total abscess and inflammatory nodule (AN) count of >= 5 at Baseline.
  • HS lesions must be present in at least 2 distinct anatomic areas at Baseline.
  • At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
  • Draining fistula count of <= 20 at Baseline.

Exclusion Criteria:

  • History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, fungal, or viral) requiring systemic treatment within 4 weeks of the Baseline visit.
  • Treatment with any investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives (whichever is longer) prior to the first dose of study drug or be currently enrolled in another interventional clinical study. Investigational drugs are also prohibited during the study.
  • Previous treatment with any cell-depleting therapies including but not limited to anti-CD20 (e.g., rituximab) within 12 months prior to Baseline or until B cell count returns to normal level or pre-treatment level.
  • Use of prescription topical therapies (including topical antibiotics) that can also be used to treat HS within 14 days prior to the Baseline visit.
  • Received any systemic (including oral) antibiotic treatment for HS or any other chronic inflammatory disorder within 14 days prior to the Baseline visit.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Quadruplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Period 1: Upadacitinib Dose A

Participants will receive Upadicitinib Dose A once daily for 16 weeks.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494
Comparatore placebo: Period 1: Placebo

Participants will receive Placebo once daily for 16 weeks.

Oral Tablets

Sperimentale: Period 2: Group 1 - Upadacitinib Dose A

Participants who were randomized to placebo in Period 1 who did not achieve HiSCR 50 (clinical non-responder, CNR) at Week 16 will receive Upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494
Comparatore placebo: Period 2: Group 2 - Placebo

Participants who were randomized to placebo in Period 1 who achieve HiSCR 50 (clinical responder, CR) at Week 16 will continue to receive placebo once daily for 20 weeks.

Oral Tablets

Sperimentale: Period 2: Group 3 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who did not achieve HiSCR 50 (CNR) at Week 16 will continue to receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494
Sperimentale: Period 2: Group 4 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494
Sperimentale: Period 2: Group 5 - Upadacitinib Dose B

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose B once daily for 20 weeks.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494
Sperimentale: Period 2: Group 6 - Placebo

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive placebo once daily for 20 weeks.

Oral Tablets

Sperimentale: Period 3: Long-Term Extension

Eligible participants will continue to receive upadacitinib or placebo for 68 weeks. Participants will be followed-up for approximately 30 days.

Oral Tablets

Altri nomi:
  • RINVOQ
  • ABT-494

Oral Tablets

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 50
Lasso di tempo: Baseline to Week 16

HiSCR 50 is defined as at least a 50% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Number of Participants with Adverse Events (AEs)
Lasso di tempo: Up to Approximately Week 108

An AE is defined as any untoward medical occurrence in a patient or clinical investigation in which a participant is administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment.

Up to Approximately Week 108

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from Baseline in Draining Fistula Count
Lasso di tempo: Baseline to Week 16

Change from baseline in draining fistula count.

Baseline to Week 16
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 75
Lasso di tempo: Baseline to Week 16

HiSCR 75 is defined as at least a 75% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Percentage of Participants Achieving Numeric Rating Scale 30 (NRS30) at Week 4 Among Participants with NRS ≥ 3 at Baseline
Lasso di tempo: Baseline to Week 4

Achievement will be considered at least a 30% reduction and at least 2 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Percentage of Participants Achieving NRS3 at Week 4 Among Participants with NRS ≥ 3 at Baseline
Lasso di tempo: Baseline to Week 4

Achievement will be considered least 3 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Change from Baseline in Hidradenitis Suppurativa Symptom Assessment (HSSA)
Lasso di tempo: Baseline to Week 16

The HSSA (24-hour recall) is a 9-item PRO questionnaire developed to assess the primary symptoms of HS in the 7 consecutive days prior to assessments. Each item of the HSSA is scored on an 11-point (0 to 10) NRS, where 0 represents no symptoms and 10 represents extreme symptom experience.

Baseline to Week 16
Change from Baseline in Hidradenitis Suppurativa Impact Assessment (HSIA)
Lasso di tempo: Baseline to Week 16

The HSIA is an 18-item PRO questionnaire developed to assess the impact of HS on the daily lives of subjects in the 7 days prior to the assessment. Items 1 - 16 of the HSIA are scored on a 0 to 10 NRS, where 0 represents no impact and 10 represents extreme impact.

Baseline to Week 16
Change from Baseline in Dermatology Life Quality Index (DLQI) for Adult Participants and Adolescent Participants Age ≥16 Years Old and Older
Lasso di tempo: Baseline to Week 16

The DLQI and the CDLQI are both 10-item questionnaires used to assess the impact of hidradenitis suppurativa (HS) disease symptoms and treatment on quality of life that consists of 10 questions scored on a 4-point scale where 0 = not at all/not relevant; 1 = a little; 2 = a lot; and 3 = very much.

Baseline to Week 16
Occurrence of Hidradenitis Suppurativa (HS) Flare During Period 1
Lasso di tempo: Baseline to Week 16

Defined as at least one occurrence of a ≥ 25% increase in AN count, with a minimum absolute increase of 2 relative to Baseline.

Baseline to Week 16

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Direttore dello studio: ABBVIE INC., AbbVie

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

21 giugno 2023

Completamento primario (Stimato)

1 agosto 2028

Completamento dello studio (Stimato)

1 agosto 2028

Date di iscrizione allo studio

Primo inviato

26 maggio 2023

Primo inviato che soddisfa i criteri di controllo qualità

26 maggio 2023

Primo Inserito (Effettivo)

5 giugno 2023

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.

Periodo di condivisione IPD

For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/

Criteri di accesso alla condivisione IPD

To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

Sì

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi